Muscarinic Antagonist - an overview | ScienceDirect Topics
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions | 2 Minute Medicine
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Journal of the COPD Foundation Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient-Powered Research N
Pharmacological management of chronic obstructive pulmonary disease
Inhaled long-acting muscarinic antagonists in asthma – A narrative review
Table 1 from Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. | Semantic Scholar
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
drugs-respiratory1.ppt
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download
Muscarinic Antagonists - AlphaNet
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis | BMC Pulmonary Medicine | Full Text
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society